Loading page...

Back
PAR-25-446 Open
Send to:
National Institutes of Health United States

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

Open Education, health Posted 10 Sep 2025
Award range Up to $3,000,000
Deadline 21 Aug 2028 647 days left

Overview

Funding agency
National Institutes of Health HHS-NIH11
Reference
PAR-25-446
Funding programme
Education, health
Funding instrument
Cooperative agreement
Cost sharing
Not required
Region
United States
Applicants based in
United States
Source
Grants.gov (US Federal)

About the funder

Funder
National Institutes of Health Research council, United States
Grants in 2025
129 Typical grant $700k
Open calls
646 open calls Giving history, how to apply, and Follow on the funder page

Description

The purpose of this Funding Opportunity (NOFO) is to solicit grant applications to support research on the discovery and development of interventions to prevent and/or treat substance use disorders (SUDs) and overdose, including medications and medical devices to treat co-morbid SUDs. This includes preclinical and clinical research studies that will have high impact and quickly yield the…

Sign up to view full grant details

Create a free account to unlock the complete grant description, funding details, eligibility criteria, and application links.

Full description Funding amounts & eligibility Application links & deadlines Save & track grants

Related grants

NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required) National Institutes of Health Closes 13 Nov 2026 NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required) National Institutes of Health Closes 13 Nov 2026 NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required) National Institutes of Health Closes 13 Nov 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed) National Institutes of Health Closes 17 Nov 2026 Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed) National Institutes of Health Closes 7 Jan 2027 Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) National Institutes of Health Closes 7 Jan 2027

Send to CRM

CRM Integration Required

To send grants directly to your CRM, you need to connect your CRM system to TenderPipe first.

Configure CRM in Settings

Email Grant

Scroll to Top